SynergenX, veteran-owned leader in personalized hormone and wellness medicine, is expanding its peptide therapy program with the addition of BPC-157 and CJC-1295 + Ipamorelin, two popular new peptide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback